Results 101 to 110 of about 182,947 (342)

Growth hormone releasing hormone. [PDF]

open access: yesArchives of Disease in Childhood, 1985
G M Besser, M O Savage
openaire   +3 more sources

Longer Acting Injectable: Continuous, Linear Release of a Progestin Contraceptive From an Oxidized Porous Silicon Host

open access: yesAdvanced Healthcare Materials, EarlyView.
Progestin drugs are loaded into a mesoporous silicon dioxide host by melt‐infiltration. Drugs that decompose at or close to their melting point can be loaded by the addition of cholesterol, which acts as a melting point suppressor. High mass loading of the drug is achieved, and dissolution of the composite is controlled by the nanoscale properties of ...
Geoffrey Hollett   +13 more
wiley   +1 more source

Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of U-87MG Human Glioblastoma in Nude Mice

open access: yesNeoplasia: An International Journal for Oncology Research, 2000
Antagonists of growth hormone-releasing hormone(GH-RH) inhibit the growth of various cancers by mechanisms that involve the suppression of the insulin-like growth factor (IGF) -I and/or IGF-II.
Hippokratis Kiaris   +2 more
doaj   +1 more source

Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model

open access: yesAdvanced Healthcare Materials, EarlyView.
This research introduces a cold plasma‐based platform for treating breast cancer bone metastases. Using a novel bioprinted 3D tumor‐stroma model, it highlights the selective antitumor effects of plasma‐generated reactive species. The platform aims to advance non‐invasive therapeutic strategies, offering potential clinical applications in controlling ...
Laura M. Bouret   +4 more
wiley   +1 more source

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

open access: yesAdvanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee   +9 more
wiley   +1 more source

Association between a High Level of Growth Hormone–Releasing Hormone (GHRH) and GHRH Genetic Polymorphism (rs566092278) with Acromegaly Cases

open access: yesMedical Journal of Babylon
Background: Acromegaly (ACM) is a rare endocrine chronic disorder. It occurs because of a benign tumor in the pituitary gland, which secretes an excess of growth hormone (GH).
Thualfiqar Ghalib Turki   +1 more
doaj   +1 more source

Reduction in Thymoma Size After Pituitary Surgery for Growth Hormone–Secreting Tumor

open access: yesAACE Clinical Case Reports, 2019
: Objective: A thymoma is a rare tumor of the anterior mediastinum and may be under the control of prolactin and growth hormone (GH), as well as GH-insulin-like growth factor 1 (IGF-1)–mediated paracrine and autocrine pathways.
Hema Padmanabhan, MD, FACP, FACE
doaj   +1 more source

Beta-endorphin: stimulation of growth hormone release in vivo. [PDF]

open access: green, 1977
Alain Dupont   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy